Search company, investor...
Search

Founded Year

2010

Stage

Series B | Alive

Total Raised

$137.99M

Last Raised

$75M | 4 mos ago

Mosaic Score

+120 points in the past 30 days

What is a Mosaic Score?
The Mosaic Score is an algorithm that measures the overall financial health and market potential of private companies.

About Digital Diagnostics

Digital Diagnostics is an AI diagnostics company on a mission to transform the quality, accessibility, and affordability of healthcare. The platform includes two autonomous AI systems, IDx-DR and 3DermSpot. The company was founded in 2010 and is based in Coralville, Iowa.

Digital Diagnostics Headquarters Location

2300 Oakdale Boulevard

Coralville, Iowa, 52241,

United States

319-248-5620

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Digital Diagnostics's Products & Differentiation

See Digital Diagnostics's products and how their products differentiate from alternatives and competitors

  • IDx-DR

    IDx-DR is a fully autonomous AI system that diagnoses diabetic retinopathy (including macular edema) in people with diabetes, in a non-eyecare setting, with an operator that has no experience with ophthalmic imaging. IDx-DR guides high quality imaging of the patient’s retina, followed by immediate autonomous analysis and diagnosis at the point-of-care. IDx-DR was designed to improve access, lower costs, and reduce health disparities to improve patient and population outcomes for people with diabetes.

    Differentiation

    Digital Diagnostics autonomous AI device, IDx-DR stands alone as the first and only FDA De Novo cleared medical device to diagnose both diabetic retinopathy and macular edema in patients with diabet… 

Expert Collections containing Digital Diagnostics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Digital Diagnostics is included in 9 Expert Collections, including Digital Health.

D

Digital Health

21,952 items

Startups recreating how healthcare is delivered

A

AI 100

100 items

A

Artificial Intelligence

9,391 items

This collection includes startups selling AI SaaS, using AI algorithms to develop their core products, and those developing hardware to support AI workloads.

D

Digital Health 150

150 items

2019's cohort of the most promising digital health startups transforming the healthcare industry

M

Medical Devices

12,428 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.

C

Conference Exhibitors

5,302 items

Digital Diagnostics Patents

Digital Diagnostics has filed 30 patents.

The 3 most popular patent topics include:

  • Medical imaging
  • Optical devices
  • Geometrical optics
patents chart

Application Date

Grant Date

Title

Related Topics

Status

3/22/2017

1/25/2022

Medical imaging, Vision, Image processing, Computer vision, Neuroimaging

Grant

Application Date

3/22/2017

Grant Date

1/25/2022

Title

Related Topics

Medical imaging, Vision, Image processing, Computer vision, Neuroimaging

Status

Grant

Latest Digital Diagnostics News

Aug. 24 Quick Takes: EC approves BioMarin’s hemophilia A gene therapy

Aug 25, 2022

Aug. 24 Quick Takes: EC approves BioMarin’s hemophilia A gene therapy Plus Ovid, Gensaic in gene therapy deal and updates from Digital Diagnostics, BioInnovation Institute , Moderna, Relief and more By BioCentury Staff August 25, 2022 1:10 AM UTC In a milestone for severe hemophilia A patients, the EC has granted conditional approval to Roctavian valoctocogene roxaparvovec from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to treat the disease and endorsed EMA’s recommendation that the gene therapy maintain orphan drug designation, giving it a 10-year period of market exclusivity. The company said it plans to submit a BLA to FDA for Roctavian, a one-time infusion that delivers a functional gene to enable the body to produce Factor VIII on its own without the need for continued hemophilia prophylaxis, by the end of September. Roctavian’s approval makes two drugs approved in Europe ahead of the U.S. in a day. The EC also granted conditional marketing authorization to Tecvayli teclistamab, a first-in-class CD3 x BCMA bispecific from Johnson & Johnson (NYSE:JNJ).

Digital Diagnostics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Digital Diagnostics Rank

  • When was Digital Diagnostics founded?

    Digital Diagnostics was founded in 2010.

  • Where is Digital Diagnostics's headquarters?

    Digital Diagnostics's headquarters is located at 2300 Oakdale Boulevard, Coralville.

  • What is Digital Diagnostics's latest funding round?

    Digital Diagnostics's latest funding round is Series B.

  • How much did Digital Diagnostics raise?

    Digital Diagnostics raised a total of $137.99M.

  • Who are the investors of Digital Diagnostics?

    Investors of Digital Diagnostics include 8VC, Optum Ventures, Frist Cressey Ventures, Gundersen Health System, OSF Ventures and 10 more.

  • Who are Digital Diagnostics's competitors?

    Competitors of Digital Diagnostics include Mindstrong, Riva Health, Verily Life Sciences, Eyenuk, Aural Analytics, Altoida, Scanwell Health, Dental Monitoring, Biospectal, Swift Medical and 16 more.

  • What products does Digital Diagnostics offer?

    Digital Diagnostics's products include IDx-DR.

  • Who are Digital Diagnostics's customers?

    Customers of Digital Diagnostics include OSF HealthCare, Alliance Chicago and Parkview Health.

You May Also Like

Binah.ai Logo
Binah.ai

Binah.ai is the developer of a real-time vital signs measurement app that only requires a smartphone, laptop, or tablet camera. Its app supports iOS devices, Android mobile devices, and Windows laptops and desktops.

Riva Health Logo
Riva Health

RIva Health is a mobile digital therapeutics platform for the cardiology industry. The company's platform aims to use mobile devices, patient-provided data, and predictive analytics to help clinicians deliver personalized therapies to patients, which leads to significant reductions in cost while increasing the number of lives saved. The company was founded in 2013 and is based in Burlingame, California.

Q
Quantiq

Quantiq transforms any webcam or smartphone into a medical device that measures heart rate, frequency rate, SpO2 and more.

Aural Analytics Logo
Aural Analytics

Aural Analytics uses speech to detect subtle but clinically meaningful changes in brain health. The platform is completely agnostic to disease, device, location and language and powers applications throughout the world. Aural Analytics was founded in 2015 and is based in Scottsdale, Arizona.

Altoida Logo
Altoida

Altoida is a digital health company utilizing active digital biomarkers and technology in AI and augmented reality (AR).

Healthy.io Logo
Healthy.io

Healthy.io is a mobile health company turning smartphone cameras into medical devices. Its first product, Dip.io, is a clinically approved home urinalysis kit that effectively turns the smartphone into a clinical grade urinalysis device, enabling the layperson to conduct clinically required urine testing with a simple smartphone scan.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.